2025³â 08¿ù 07ÀÏ ¸ñ¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > Àαⴺ½º

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýȰ

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óǰ

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
 
¸ðµÎ 92542°³ÀÇ ´º½º°¡ °Ë»öµÇ¾ú½À´Ï´Ù.



ÅÂÇ×È£, MBC ¡®¸Þ¸® ųÁî ÇÇÇᯠÃ⿬

ºÎÇü»ç·Î º¯½Å, Á¶·Â»ç¸Á »ç°Ç ÃßÀû
¹è¿ì ÅÂÇ×È£°¡ Áö³­ 1ÀÏ Ã¹ ¹æ¼ÛµÈ MBC ±ÝÅäµå¶ó¸¶ ‘¸Þ¸® ųÁî ÇÇÇÃ’(±âȹ ±Ç¼ºÃ¢ / ¿¬Ãâ ¹ÚÁØ¿ì / ±Øº» À̼ö¾Æ / Á¦ÀÛ ¹Ì½ºÅͷθǽº, ¹«ºùÇÈÃĽºÄÄÆÛ´Ï, ½ºÆ©µð¿À ¾ÈÀÚÀÏ·»)À» ÅëÇØ ½ÃûÀÚµé°ú ¸¸³µ´Ù.   ‘¸Þ¸® ųÁî ÇÇÇÃ’Àº Ä¡·á°¡ ºÒ°¡´ÉÇÑ È¯ÀÚµéÀÇ Á¶·Â »ç¸ÁÀ» µ½´Â ÀÇ»ç¿Í À̸¦ ÃßÀûÇÏ´Â Çü»çÀÇ À̾߱⸦ ±×¸° ¼­½ºÆæ½º µå¶ó¸¶´Ù.   ±Ø Áß ÅÂÇ×È£´Â ±¤¼ö´ëÀå żº(±èÅÂ¿ì ºÐ)°ú ÇÔ²² »ç°ÇÀ» ÂÑ´Â ‘ºÎÇü»ç’·Î ºÐÇØ, Á¶·Â »ç¸Á »ç°ÇÀÇ ½Çü¿¡ ´Ù°¡¼­±â À§ÇØ ÇöÀåÀ» ´©ºñ°í ´Ü¼­¸¦ ...

KGM, Áö´ÉÇüÀÚµ¿Â÷ºÎǰÁøÈï¿ø°ú ÀÚÀ²ÁÖÇà ±â¼úÇù·Â MOU

ÀÚÀ²ÁÖÇà °ü·Ã À¯·´ ¹ý±Ô ´ëÀÀÀº ¹°·Ð ¾ç»ê ±â¼ú È®º¸ ±â´ë
KG ¸ðºô¸®Æ¼(ÀÌÇÏ KGM)°¡ Áö´ÉÇüÀÚµ¿Â÷ºÎǰÁøÈï¿ø (ÀÌÇÏ ÁøÈï¿ø)°ú ÀÚÀ²ÁÖÇà ±â¼ú °³¹ß MOU¸¦ ü°áÇÏ°í »óÈ£Çù·ÂÇϱâ·Î Çß´Ù. Áö³­ 28ÀÏ(¿ù) ÁøÈï¿ø º»»ç(´ë±¸½Ã ´Þ¼º±º ¼ÒÀç)¿¡¼­ ¿­¸° MOU ü°á½Ä¿¡´Â KGM ±Ç¿ëÀÏ ±â¼ú¿¬±¸¼Ò ¼ÒÀå°ú ÁøÈï¿ø ¼­ÀçÇü ¿øÀåÀ» ºñ·ÔÇÑ °ü°èÀÚµéÀÌ Âü¼®Çß´Ù. ÁøÈï¿øÀº ÀÚÀ²ÁÖÇàÂ÷ µî Â÷¼¼´ë ÀÚµ¿Â÷ ±â¼úÀ» °³¹ßÇÏ´Â °ü·Ã ¾÷ü¿Í ¿¬±¸±â°üÀ» Áö¿øÇϱâ À§ÇØ 2014³â ¼³¸³µÈ ½ÃÇè Àü¹® ±â°üÀ¸·Î, °í¼Ó ÁÖȸ·Î, ¹ü¿ë ½ÃÇè·Î µî ´Ù¾çÇÑ Á¶°Ç¿¡¼­ÀÇ ÀÚµ¿Â÷ ÁÖÇà ½ÃÇè ¹× Ãæ°Ý ³»±¸ ½ÃÇè Àåºñ µîÀÇ ½Ã¼³ ¹× ½ÃÇè Àη ...

Novotech Report: How In-Vivo CAR-T May Reshape Cell Therapy Econo...
SYDNEY -- With in-vivo CAR-T therapies gaining global momentum, a new whitepaper from Novotech, a leading global full-service clinical Contract Research Organization (CRO) and scientific advisory company, offers insight into this next frontier of immunotherapy. In-Vivo CAR Therapies - Global Research and Development Landscape (2025) report explores the accelerating innovation in in-vivo CAR-T (Chimeric Antigen Receptor) technologies and their potential to reshape treatment across oncology, autoi ...
SK, Ú¸ ͏®Æ÷´Ï¾Æ¿¡¼­ ¡®SK ±Û·Î¹ú Æ÷·³¡¯ °³ÃÖ (2022-06-15)
±èÀ¯Á¤, ¿©¼º½º·¯¿ò°ú ¼º¼÷¹Ì°¡ °¡µæÇÑ È­º¸ (2018-10-19)
¹è¿ì Á¶Àμº, ¼­¿ï¼ÛÆÄ°æÂû¼­ È«º¸´ë»ç À§ÃË (2018-10-19)
2022 ´ëÇѹα¹ÀÌ ¿­±¤ÇÒ ½Ã´Ï¾î Æ®·»µå (2021-12-12)
Çö´ëÂ÷, ÄܼÁƮī HED-9 ¡®ÀÎÆ®¶óµµ¡¯ °ø°³ (2014-02-25)
¾Ë¹Ù»ý 40.3% ¡®½ºÄ«¿ìÆ® Á¦ÀÇ ¹Þ¾ÆºÃ´Ù¡¯ (2021-06-10)
trend_hunt, 18FW ·èºÏ °ø°³ (2018-11-12)
±ºÁý¼ö»ö ÀÚÀ²¹«ÀÎÀá¼öÁ¤ °³¹ß Âø¼ö (2021-06-18)
¹ß´ÞÀå¾Ö ij¸¯Å͵ðÀÚÀÎ Àü¹®°¡ ¾ç¼º (2022-07-01)
ºÒ¹ý º¹Á¦¡¤Àü¼ÛÀÚ¿¡ ´ëÇÑ Á¤º¸Á¦°ø ¸í·É (2013-03-16)
SKT, ¿¬¸»¿¬½Ã Ưº° ¼ÒÅë ´ëÃ¥ ¹ßÇ¥ (2021-12-28)
ÀνºÅ¸±×·¥, ½Å¿¹ ¸ðµ¨ÀÇ »õ·Î¿î µî¿ë¹®À¸·Î (2015-10-29)
ÀÚ´ãġŲ, ġŲ ºê·£µå Áß °í°´Ã漺µµ ÃÖ»óÀ§ (2020-06-21)
±ÝÀ¶µð¿À¾¾, ±ÝÀ¶ Ç÷§Æû ±â¼ú ƯÇã Ãâ¿ø (2022-01-05)
Ãæ³² °ü±¤ Ȱ¼ºÈ­, °í±Þ ¼÷¹Ú½Ã¼³¡¤´ëÁß±³Åë È®Ãæ ÇØ¾ß (2022-07-17)
'ÇÑ-·¯ ¾î¸°ÀÌ È£¶ûÀÌ ±×¸®±â ´ëȸ¡¯ ½Ã»ó½Ä (2022-01-13)
'Çѱ¹ ¹®ÇÐÀÇ ¹Ì·¡°¡ µÉ ÀþÀº ÀÛ°¡¡¯ »Ì´Â ÅõÇ¥ (2021-07-12)
¼ºÀÎ 46.9%, Á÷Àå ¼±Åà ±âÁØ 1À§´Â ¡®¿¬ºÀ¡¯ (2021-01-08)
½Ö¿ëÂ÷, 8³â¸¸¿¡ ¾ÆÇÁ¸®Ä« ¼ö´Ü ½ÃÀå ÀçÁøÃâ (2017-12-25)
¾Ë¹Ù¸ó, ³ëµ¿¿ä ¡®ÇϰԵȴٵȴ٠SONG¡¯ À½¿ø ¹ß¸Å (2020-07-15)
ÃãÆÇ ¿öÅ©¼ó ³í¶õ ¹èµ¿¿í Áß¾ÓȸÀå ÅðÁøÇ϶ó (2020-07-15)
´Ö»ê µô·¯ , 1¸¸1111¹øÂ° Ãâ°í °í°´ À̺¥Æ® ´ç÷ÀÚ ¹ßÇ¥ (2018-07-22)
3PM, ¶óÀ̺ê ÄÃó NFT ¸â¹ö½Ê ¡®µðÁöƾ¡¯ °ø°³ (2023-02-03)
³óÃÌ Çö½Ç ¹Ý¿µÇÑ °æ°üº¸ÀüÁ÷ºÒÁ¦·Î °³¼±ÇØ¾ß (2023-02-03)
½Å¿ëº¸Áõ±â±Ý ¡¤ Çѱ¹ÇؾçÁøÈï°ø»ç ä¿ë (2021-08-05)
       [ÀÌÀü][1]....[2472][2473][2474][2475][2476][2477][2478][2479][2480]...[3702][´ÙÀ½]

°øÁö»çÇ×
´º½ºÁö ÇÑÀÚ Ç¥±â¿¡ ´ë¸¸½Ä À½Â÷ Ç¥±â '纽ÞÙó¢ ´Ï¿ì½ÃÁö' º´±â
º£³×ÇÁ·Ò º£³×ÀÎÅõ Áß¹® Ç¥±â 宝Ò¬ÜØÙÌ 宝Ò¬ì×öõ(ÜÄÒ¬ÜØÙÌ ÜÄ...
¹Ìµð¾î¾Æ¿ì¾î Mediaour ØÚ体ä²们 ØÚô÷ä²Ùú MO ¿¥¿À ØÚä² ØÚä²
¾Ë¸®¿ìºê Alliuv ä¹备: ä¹联êó备, ¾Ë¶ã Althle ä¹÷åìÌ
¾Ë¸®¾Ë Allial Áß¹® Ç¥±â ä¹××尔 ä¹××ì³
´ºÆÛ½ºÆ® New1st Áß¹® Ç¥±â 纽ììãæ(¹øÃ¼ Òïììãæ), N1 纽1
¿£ÄÚ½º¸ð½º : À̾¾ 'EnCosmos : EC' Áß¹® Ç¥±â ì¤ñµ
¾ÆÀ̵ð¾î·Ð Idearon Áß¹® Ç¥±â ì¤îè论 ì¤îèÖå
¹ÙÀÌ¿ÀÀÌ´Ï Bioini Áß¹® Ç¥±â ù±药研 ù±å·æÚ
¿À½ºÇÁ·Ò Ausfrom 奥ÞÙÜØÙÌ, À£ÇÁ·Ò Welfrom 卫ÜØÙÌ
¿¡³ÊÇÁ·Ò Enerfrom 额ÒöÜØÙÌ ¿¡³ÊÀ¯ºñ Eneruv 额Òöêó备
¾ËÇÁ·Ò Alfrom Áß¹® Ç¥±â ä¹尔ÜØÙÌ ä¹ì³ÜØÙÌ
 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, ÆÑ½º 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..